Samil Pharmaceutical Co.,Ltd (KRX: 000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
17,060
+900 (5.57%)
Oct 8, 2024, 3:30 PM KST
157.70%
Market Cap 351.69B
Revenue (ttm) 210.73B
Net Income (ttm) -1.16B
Shares Out 21.14M
EPS (ttm) -74.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close 16,160
Day's Range 17,060 - 17,060
52-Week Range 17,060 - 17,700
Beta 0.34
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Samil Pharmaceutical Co.,Ltd

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se... [Read more]

Sector Healthcare
Founded 1947
Employees 586
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.